
AIP
Arteris Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
10.585
Open
9.780
VWAP
10.25
Vol
702.28K
Mkt Cap
445.27M
Low
9.6356
Amount
7.20M
EV/EBITDA(TTM)
--
Total Shares
38.48M
EV
385.52M
EV/OCF(TTM)
--
P/S(TTM)
6.33
Arteris, Inc. is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its System IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. It provides semiconductor interconnect IP and SoC Integration Automation software solutions to serve its target end-markets, including automotive, enterprise computing, consumer electronics, communications across wired and wireless, and industrial markets. Its two core product platforms are Network-on-Chip IP Products and SoC Integration Automation Software Solutions Products. Its Network-on-Chip IP products include Non-coherent NoC IP, with FlexGen, FlexNoC and FlexWay; Cache-coherent NoC IP, with Ncore, and NoC interface IP, with CodaCache. Its SoC Integration Automation Software Solutions products include IP and SoC software, with Magillem (Connectivity and Registers) and CSRCompiler.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
18.42M
+11.42%
-0.065
-27.78%
18.09M
+16.8%
-0.072
-27.5%
17.00M
+15.54%
-0.092
+15.62%
Estimates Revision
The market is revising No Change the revenue expectations for Arteris, Inc. (AIP) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 20.14%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Up

+20.14%
In Past 3 Month
3 Analyst Rating
Wall Street analysts forecast AIP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AIP is 15.00 USD with a low forecast of 14.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 10.440

Low
14.00
Averages
15.00
High
16.00
Current: 10.440

Low
14.00
Averages
15.00
High
16.00
TD Cowen
Joshua Buchalter
Buy
maintain
$12 -> $15
2025-08-06
Reason
TD Cowen
Joshua Buchalter
Price Target
$12 -> $15
2025-08-06
maintain
Buy
Reason
TD Cowen analyst Joshua Buchalter raised the firm's price target on Arteris to $15 from $12 and keeps a Buy rating on the shares. The firm updated its model following Q2 results as its print/guide showcased all KPIs exceeding expectations. FY25 guidance is expected higher supported by record RPO, underscoring sustained momentum.
TD Cowen
Buy
maintain
$8 -> $10
2025-05-14
Reason
TD Cowen
Price Target
$8 -> $10
2025-05-14
maintain
Buy
Reason
TD Cowen raised the firm's price target on Arteris to $10 from $8 and keeps a Buy rating on the shares. The firm updated its model following inline Q1 results with licensing upside, though 2Q guidance was a bit light versus the firm's model.
Rosenblatt
Hans Mosesmann
Strong Buy
Maintains
$15
2025-02-19
Reason
Rosenblatt
Hans Mosesmann
Price Target
$15
2025-02-19
Maintains
Strong Buy
Reason
Northland Capital Markets
Gus Richard
Buy
Maintains
$14 → $16
2025-02-19
Reason
Northland Capital Markets
Gus Richard
Price Target
$14 → $16
2025-02-19
Maintains
Buy
Reason
Northland analyst Gus Richard raised the firm's price target on Arteris to $16 from $14 and keeps an Outperform rating on the shares. Arteris reported an in-line quarter for revenue and guided in-line, but "these numbers miss bookings and new product momentum," the analyst tells investors in a post-earnings note.
Rosenblatt
Hans Mosesmann
Strong Buy
Maintains
$15
2025-02-18
Reason
Rosenblatt
Hans Mosesmann
Price Target
$15
2025-02-18
Maintains
Strong Buy
Reason
Rosenblatt
Hans Mosesmann
Strong Buy
Maintains
$15
2024-11-06
Reason
Rosenblatt
Hans Mosesmann
Price Target
$15
2024-11-06
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Arteris Inc (AIP.O) is -38.31, compared to its 5-year average forward P/E of -18.54. For a more detailed relative valuation and DCF analysis to assess Arteris Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-18.54
Current PE
-38.31
Overvalued PE
-8.69
Undervalued PE
-28.38
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-23.64
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
-4.14
Undervalued EV/EBITDA
-43.15
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
5.45
Current PS
0.00
Overvalued PS
8.44
Undervalued PS
2.47
Financials
Annual
Quarterly
FY2025Q2
YoY :
+13.22%
16.50M
Total Revenue
FY2025Q2
YoY :
+10.85%
-8.25M
Operating Profit
FY2025Q2
YoY :
+9.42%
-9.13M
Net Income after Tax
FY2025Q2
YoY :
-0.00%
-0.22
EPS - Diluted
FY2025Q2
YoY :
-1175.76%
-2.84M
Free Cash Flow
FY2025Q2
YoY :
-0.62%
89.44
Gross Profit Margin - %
FY2025Q2
YoY :
-75.42%
-2.77
FCF Margin - %
FY2025Q2
YoY :
-3.35%
-55.33
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
5.7M
USD
35
3-6
Months
1.1M
USD
25
6-9
Months
2.4M
USD
25
0-12
Months
5.3M
USD
40
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
5.7M
USD
35
3-6
Months
1.1M
USD
25
6-9
Months
2.4M
USD
25
0-12
Months
5.3M
USD
40
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
AIP News & Events
Events Timeline
2025-08-26 (ET)
2025-08-26
09:03:33
Arteris Partners with UALink Consortium to Speed Up AI Network Expansion

2025-08-05 (ET)
2025-08-05
16:53:16
Arteris narrows FY25 revenue view to $66M-$70M from $65M-$71M

2025-08-05
16:52:01
Arteris sees Q3 revenue $16.8M-$17.2M, consensus $17.25M

Sign Up For More Events
Sign Up For More Events
News
9.5
08-06NewsfilterArteris, Inc. (AIP) Q2 2025 Earnings Call Transcript
7.0
08-05SeekingAlphaArteris targets $72M–$78M ACV plus royalties for 2025, advances FlexGen adoption and multi-die solutions
8.0
08-05NASDAQ.COMNoteworthy Tuesday Option Activity: HAE, AIP, MSTR
Sign Up For More News
People Also Watch

MLYS
Mineralys Therapeutics Inc
38.780
USD
-1.25%

GCBC
Greene County Bancorp Inc
23.840
USD
-0.63%

TWFG
TWFG Inc
25.970
USD
+3.47%

AROW
Arrow Financial Corp
29.210
USD
-0.51%

SWBI
Smith & Wesson Brands Inc
9.380
USD
0.00%

DCTH
Delcath Systems Inc
11.550
USD
+0.09%

ARCT
Arcturus Therapeutics Holdings Inc
21.030
USD
+2.79%

CLCO
Cool Company Ltd
7.670
USD
-1.92%

BWMN
Bowman Consulting Group Ltd
43.890
USD
+2.28%
FAQ

What is Arteris Inc (AIP) stock price today?
The current price of AIP is 10.44 USD — it has increased 5.78 % in the last trading day.

What is Arteris Inc (AIP)'s business?

What is the price predicton of AIP Stock?

What is Arteris Inc (AIP)'s revenue for the last quarter?

What is Arteris Inc (AIP)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Arteris Inc (AIP)'s fundamentals?

How many employees does Arteris Inc (AIP). have?
